Paola Devoto
Cagliari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals.
Journal: Frontiers in pharmacology
Published: June 10, 2023
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride.
Journal: Neuropharmacology
Published: November 03, 2021
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats.
Journal: International journal of molecular sciences
Published: January 07, 2021
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.
Journal: Frontiers in pharmacology
Published: July 28, 2020
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation.
Journal: Neurobiology of aging
Published: May 19, 2020
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients.
Journal: Scientific reports
Published: March 07, 2019
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation.
Journal: Neuropharmacology
Published: December 12, 2018
Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress.
Journal: Neuropharmacology
Published: September 20, 2018
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone.
Journal: Nature neuroscience
Published: September 14, 2018
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: July 23, 2018
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.
Journal: CNS neuroscience & therapeutics
Published: June 30, 2018
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.
Journal: Neurobiology of disease
Published: June 01, 2018
Last Updated: 09/26/2026